Anticoagulant Treatment Regimens in Patients With Covid‐19: A Meta‐Analysis
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2504
Abstract: Coronavirus disease 2019 (COVID‐19) is associated with a hypercoagulable state. It has been hypothesized that higher‐dose anticoagulation, including therapeutic‐dose and intermediate‐dose anticoagulation, is superior to prophylactic‐dose anticoagulation in the treatment of COVID‐19. This meta‐analysis evaluated… read more here.
Keywords: patients covid; dose anticoagulation; higher dose; prophylactic dose ... See more keywords
Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Rheumatology"
DOI: 10.1007/s10067-018-4005-6
Abstract: The objective of this study was to investigate risk factors for cytopenia when a prophylactic dose of trimethoprim-sulfamethoxazole (TMP-SMX) was co-administered with methotrexate (MTX). Patients who received MTX with or without a prophylactic dose of… read more here.
Keywords: dose; dose tmp; prophylactic dose; tmp smx ... See more keywords
Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14040737
Abstract: Background: Therapeutic/intermediate-dose heparin reduces the risk of thromboembolic events but increases the risk of major bleeding in patients hospitalized for acute COVID-19 pneumonia. Objectives: To prospectively assess the incidence of objectively proven venous thromboembolism (VTE)… read more here.
Keywords: acute covid; prophylactic dose; risk; covid pneumonia ... See more keywords
In patients hospitalized with COVID-19, therapeutic- vs. prophylactic-dose heparin did not reduce a composite outcome at 28 d
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j21-0020
Abstract: SOURCE CITATION Sholzberg M, Tang GH, Rahhal H, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital:… read more here.
Keywords: patients hospitalized; covid therapeutic; hospitalized covid; heparin ... See more keywords
In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j21-0021
Abstract: SOURCE CITATION Ortega-Paz L, Galli M, Capodanno D, et al. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled… read more here.
Keywords: dose anticoagulation; anticoagulation; anticoagulation reduce; prophylactic dose ... See more keywords